tiprankstipranks
MedAdvisor Limited (AU:MDR)
ASX:MDR
Australian Market

MedAdvisor Limited Stock Price & Analysis

0 Followers

MDR Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.14 - AU$0.42
Previous CloseAU$0.14
Volume100.16K
Average Volume (3M)426.14K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$4.40M
Total Debt (Recent Filing)AU$1.42M
P/E Ratio-3.0
Beta0.67
Next EarningsFeb 28, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-0.04
Shares Outstanding543,187,811
R-Squared0.02
Standard Deviation0.12
10 Day Avg. Volume531,123
30 Day Avg. Volume426,141
P/B Ratio-3.49
P/S Ratio2.93
P/CF RatioN/A
P/FCF Ratio-243.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha0.01
Number of Analyst Covering0


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

MDR FAQ

What was MedAdvisor Limited’s price range in the past 12 months?
MedAdvisor Limited lowest stock price was AU$0.14 and its highest was AU$0.41 in the past 12 months.
    What is MedAdvisor Limited’s market cap?
    Currently, no data Available
    When is MedAdvisor Limited’s upcoming earnings report date?
    MedAdvisor Limited’s upcoming earnings report date is Feb 28, 2023 which is in 150 days.
      How were MedAdvisor Limited’s earnings last quarter?
      MedAdvisor Limited released its earnings results on Aug 25, 2022. The company reported -AU$0.026 earnings per share for the quarter, missing the consensus estimate of -AU$0.008 by -AU$0.018.
        Is MedAdvisor Limited overvalued?
        According to Wall Street analysts MedAdvisor Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MedAdvisor Limited pay dividends?
          MedAdvisor Limited does not currently pay dividends.
          What is MedAdvisor Limited’s EPS estimate?
          MedAdvisor Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does MedAdvisor Limited have?
          MedAdvisor Limited has 543,187,800 shares outstanding.
            What happened to MedAdvisor Limited’s price movement after its last earnings report?
            MedAdvisor Limited reported an EPS of -AU$0.026 in its last earnings report, missing expectations of -AU$0.008. Following the earnings report the stock price went down -6.667%.
              Which hedge fund is a major shareholder of MedAdvisor Limited?
              Currently, no hedge funds are holding shares in AU:MDR

              ---

              MedAdvisor Limited Stock Analysis

              Smart ScoreNeutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              5
              The MedAdvisor Limited Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              MedAdvisor Limited

              MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has five reporting segments: MedAdvisor; USA, UK, and Asia, and corporate. The company derives most of its revenues from MedAdvisor.

              ---
              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis